Jim Simons
PRVA icon

Jim Simons’s Privia Health PRVA Stock Holding History

Jim Simons’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16M Buy
776,500
+262,500
+51% +$5.92M 0.03% 745
2025
Q4 		$12.2M Sell
514,000
-62,300
-11% -$1.52M 0.02% 824
2025
Q3 		$14.3M Sell
576,300
-2,800
-0.5% -$60.3K 0.02% 893
2025
Q2 		$13.3M Buy
579,100
+268,700
+87% +$6.22M 0.02% 903
2025
Q1 		$6.97M Buy
310,400
+92,300
+42% +$2.14M 0.01% 1218
2024
Q4 		$4.26M Sell
218,100
-48,200
-18% -$955K 0.01% 1546
2024
Q3 		$4.85M Buy
266,300
+201,800
+313% +$3.85M 0.01% 1459
2024
Q2 		$1.12M Buy
+64,500
New +$1.14M ﹤0.01% 2259
2023
Q3 		– Sell
-132,409
Closed -$3.46M – 4008
2023
Q2 		$3.46M Sell
132,409
-328,600
-71% -$8.68M 0.01% 1638
2023
Q1 		$12.7M Buy
461,009
+75,100
+19% +$1.98M 0.02% 961
2022
Q4 		$8.76M Buy
385,909
+238,709
+162% +$6.64M 0.01% 1168
2022
Q3 		$5.01M Buy
147,200
+18,800
+15% +$695K 0.01% 1439
2022
Q2 		$3.74M Buy
128,400
+74,300
+137% +$1.89M ﹤0.01% 1766
2022
Q1 		$1.45M Buy
+54,100
New +$1.28M ﹤0.01% 2464

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Jim Simons's PRVA Position: Q1 2026 in Review

Jim Simons increased its Privia Health (PRVA) stake by 51% in Q1 2026, buying an estimated $5.92M and bringing the position to 776,500 shares worth $16M. The position accounts for 0.03% of the portfolio, ranked #745.

Jim Simons first reported a position in PRVA in Q1 2022 and has held it in 14 quarters since. 293 funds tracked by Wall St. Rank hold PRVA as of Q1 2026.

  • Jim Simons held 776,500 shares of Privia Health worth $16M as of Q1 2026.
  • Jim Simons bought 262,500 Privia Health shares in Q1 2026, an estimated $5.92M.
  • Privia Health made up 0.03% of Jim Simons's portfolio in Q1 2026, its #745 holding.
  • Jim Simons first reported a position in Privia Health in Q1 2022 and has held it in 14 quarters since.
  • 293 funds tracked by Wall St. Rank held Privia Health as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.